Abstract
Attention-deficit/hyperactivity disorder (ADHD) symptoms, including inattention and over activity, occur in approximately one-third of children with autism spectrum disorder (ASD). We describe the rate and duration of adverse events in a randomized controlled trial of atomoxetine (ATX) and parent training (PT) for ADHD symptoms and noncompliance in children with ASD. We conducted a 10-week, double-blind, 2 × 2 trial of ATX and PT with 128 children (ages 5-14) randomized to ATX alone, ATX+PT, placebo+PT, or placebo alone. For 6 weeks, ATX (or placebo) doses were clinically adjusted to a maximum of 1.8 mg/(kg·day) and maintained for an additional 4 weeks. An average of seven PT sessions were conducted in the two PT arms. Adverse events (AEs) were assessed through parent ratings of common symptoms on a seven-point Likert severity scale and through direct interviews with study medical staff. ATX was associated with decreased appetite and fatigue, but was otherwise well tolerated. Most reported AEs lasted 4 weeks or less. Unlike reports with typically developing (TD) children, there were no concerns with QTc changes or suicidal ideation. This study extends the findings of previous studies of ATX in ASD by documenting that the type o...Continue Reading
References
Oct 31, 2000·Journal of Autism and Developmental Disorders·B L HandenM Lubetsky
Jul 18, 2006·Journal of Autism and Developmental Disorders·Ovsanna T LeyferJanet E Lainhart
Sep 28, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·L Eugene ArnoldYaser Ramadan
Mar 4, 2008·Assessment·Regina BussingJames M Swanson
Mar 7, 2009·Journal of the American Board of Family Medicine : JABFM·Xiangyang JiaoMelvyn Bleiberg
Nov 3, 2011·The New England Journal of Medicine·William O CooperWayne A Ray
May 1, 2012·Brain & Development·Arianna BenvenutoPaolo Curatolo
Jun 23, 2012·Journal of the American Academy of Child and Adolescent Psychiatry·Myriam HarfterkampPieter J Hoekstra
Nov 9, 2012·Pediatrics·Darryn M SikoraDaniel Rosenberg
Oct 15, 2013·Expert Review of Neurotherapeutics·Kevin M AntshelStephen V Faraone
Jan 30, 2014·Journal of the American Academy of Child and Adolescent Psychiatry·Shimon Schwartz, Christoph U Correll
Sep 1, 2015·The American Journal of Psychiatry·Lawrence ScahillUNKNOWN Research Units on Pediatric Psychopharmacology Autism Network
Oct 28, 2015·Journal of the American Academy of Child and Adolescent Psychiatry·Benjamin L HandenTristram Smith
Jan 23, 2016·Journal of Child and Adolescent Psychopharmacology·Jill A HollwayTristram Smith
Sep 25, 2016·Journal of the American Academy of Child and Adolescent Psychiatry·Tristram SmithBenjamin L Handen
Citations
Nov 8, 2017·Journal of Child and Adolescent Psychopharmacology·Jill A HollwayTristram Smith
Apr 26, 2018·Journal of Child and Adolescent Psychopharmacology·L Eugene ArnoldRobert Rice
Jan 18, 2019·Autism Research : Official Journal of the International Society for Autism Research·Suravi PatraRichard Kirubakaran
Oct 19, 2019·Journal of Attention Disorders·J J MuitC C Kan
May 13, 2020·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marco SolmiChristoph U Correll
Aug 28, 2020·Journal of Child Psychology and Psychiatry, and Allied Disciplines·Rebecca RodriguesStephanie H Ameis
Apr 16, 2021·Progress in Neuro-psychopharmacology & Biological Psychiatry·Antonio M PersicoCelso Arango